'Unprecedented' Survival Seen With Maintenance Tarlatamab for SCLC in Early Study

(MedPage Today) — The combination of tarlatamab (Imdelltra) and a PD-L1 inhibitor after first-line chemo-immunotherapy showed promise as a maintenance therapy in patients with extensive-stage small cell lung cancer (ES-SCLC), with a manageable…

Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117402

Author :

Publish date : 2025-09-10 18:32:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

‘Unprecedented’ Survival Seen With Maintenance Tarlatamab for SCLC in Early Study

Large Physician Group Call for RFK Jr.’s Removal

Bispecific Antibody Improves PFS in EGFR-Mutated Lung Cancer

Related Posts

Is Tylenol Linked to Infant Eczema?

Antibody Prevention of RSV in Infants; Medical Imaging and Cancer Risk in Kids

Trusted Vaccine Guidance Has Collapsed — Along With the Rule of Law

Considering GLP-1 Agonists for Patients With Psoriasis, HS

It’s Time to Get a Flu Vaccination. Here’s Who Needs One and Why.

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say

Is Tylenol Linked to Infant Eczema?

Antibody Prevention of RSV in Infants; Medical Imaging and Cancer Risk in Kids

Trusted Vaccine Guidance Has Collapsed — Along With the Rule of Law

Considering GLP-1 Agonists for Patients With Psoriasis, HS

It’s Time to Get a Flu Vaccination. Here’s Who Needs One and Why.

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say

Ahead of Shutdown, Most Americans Said They Wanted ACA Tax Credits Extended

Medical Groups Call for Physician Exemptions to Trump’s Executive Order

Categories

Archives